Form 8-K - Current report:
SEC Accession No. 0001437749-25-006379
Filing Date
2025-03-06
Accepted
2025-03-06 08:30:16
Documents
14
Period of Report
2025-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20250305_8k.htm   iXBRL 8-K 27682
  Complete submission text file 0001437749-25-006379.txt   155789

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dmac-20250228.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20250228_def.xml EX-101.DEF 11028
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20250228_lab.xml EX-101.LAB 14741
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20250228_pre.xml EX-101.PRE 11133
17 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20250305_8k_htm.xml XML 2731
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 25713701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)